Keyphrases
Endothelial Dysfunction
100%
Mesenchymal Stem Cells
100%
Monocrotaline
100%
Monocrotaline-induced Pulmonary Hypertension
100%
Intratracheal
100%
Acetylcholine
42%
Lung Parenchyma
28%
Pulmonary Artery Pressure
28%
Pulmonary Vascular Resistance
28%
Vasodilator
14%
Intravenous Injection
14%
α-smooth muscle Actin (α-SMA)
14%
Lung
14%
Immunohistochemical Study
14%
LacZ
14%
Vascular Resistance
14%
Immunofluorescence Study
14%
Airway
14%
Systemic Response
14%
Sodium Nitroprusside
14%
Paracrine Effect
14%
Endothelium-dependent
14%
Endothelium-dependent Vasodilation
14%
Widespread Distribution
14%
Pulmonary Artery
14%
Pulmonary Vascular
14%
Vascular Endothelial Function
14%
Right Ventricular Hypertrophy
14%
Pulmonary Hypertension Treatment
14%
Von Willebrand Factor
14%
Pulmonary Response
14%
Rat Mesenchymal Stem Cells
14%
Pressure Resistance
14%
Smooth muscle Phenotype
14%
Intratracheal Administration
14%
Pulmonary Vascular Response
14%
Intratracheal Injection
14%
Medicine and Dentistry
Endothelial Dysfunction
100%
Mesenchymal Stem Cell
100%
Monocrotaline
100%
Monocrotaline-Induced Pulmonary Hypertension
100%
Acetylcholine
42%
Vasodilator Agent
28%
Lung Vascular Resistance
28%
Lung Parenchyma
28%
Intratracheal Drug Administration
28%
Lung Artery Pressure
28%
Vascular Resistance
14%
Blood Vessel Reactivity
14%
Smooth Muscle
14%
Immunofluorescence
14%
Intravenous Drug Administration
14%
Smooth Muscle Actin
14%
Endothelial Function
14%
Pulmonary Hypertension
14%
Von Willebrand Factor
14%
Sodium Nitroprusside
14%
Right Ventricular Hypertrophy
14%
Lung
14%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Dysfunction
100%
Monocrotaline-Induced Pulmonary Hypertension
100%
Monocrotaline
100%
Acetylcholine
42%
Vasodilator Agent
28%
Smooth Muscle Actin
14%
Nitroprusside Sodium
14%
Heart Right Ventricle Hypertrophy
14%
Von Willebrand Factor
14%
Pulmonary Hypertension
14%